GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Homology Medicines Inc (STU:35H) » Definitions » 5-Year Yield-on-Cost %

Homology Medicines (STU:35H) 5-Year Yield-on-Cost % : 0.00 (As of Jun. 08, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Homology Medicines 5-Year Yield-on-Cost %?

Homology Medicines's yield on cost for the quarter that ended in Dec. 2023 was 0.00.


The historical rank and industry rank for Homology Medicines's 5-Year Yield-on-Cost % or its related term are showing as below:



STU:35H's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.87
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Homology Medicines's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Homology Medicines's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Homology Medicines's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Homology Medicines's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Homology Medicines's 5-Year Yield-on-Cost % falls into.



Homology Medicines 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Homology Medicines is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Homology Medicines  (STU:35H) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Homology Medicines 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Homology Medicines's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Homology Medicines (STU:35H) Business Description

Traded in Other Exchanges
Address
One Patriots Park, Bedford, MA, USA, 01730
Homology Medicines Inc is a United States-based genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a range of genetic disorders.

Homology Medicines (STU:35H) Headlines

No Headlines